Columnist Oluwatosin Adesoye once feared how sickle cell complications would affect her future, but they ended up opening ...

CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to ...

The U.S. Food and Drug Administration is speeding up its review of an oral medicine for sickle cell disease that may fill a ...

Casgevy is now approved in the U.S. for children with sickle cell as young as 2, becoming the first gene-editing therapy for ...

Wilson reflects on the fruits of progress in sickle cell advocacy, leading to a new generation of possibility.

Sickle cell disease (SCD) prognosis varies depending on disease severity and other factors, but the overall life expectancy for the inherited blood disorder has increased notably over recent decades.

Mutations in the HBB gene cause SCD by leading to the production of a faulty version of hemoglobin (the protein that helps red blood cells transport oxygen), which tends to clump inside red blood ...

On Dec. 8, the U.S. Food and Drug Administration (FDA) approved two cell-based gene therapies for sickle cell disease (SCD), a groundbreaking decision that now offers patients more than one ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Although approximately 1 in 6 people worldwide are living with a ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...